Clinical Research Management, a Full-Service CRO, Changes Its Name to ClinicalRM
Clinical Research Management announced it is changing its name to ClinicalRM to support the company’s strategic business growth and to better differentiate itself among providers of clinical trial and research services for both pharmaceuticals and medical devices.
In conjunction with the name change, ClinicalRM is also launching a new website designed to increase communication to sponsors and partners regarding their range of capabilities and sponsor services.
When asked about a name change, Victoria Tifft, CEO and Founder of ClinicalRM responded, “When we started our business nearly two decades ago, Web URLs and e-mail addresses had very little to do with an identity. Since then, the world has come to rely on your web identity as your corporate identify. In this day and age, we need to make it easy for our prospective clients to find us and hear the ClinicalRM story.”
When asked “Why now?” Ms. Tifft described the growth strategies put in place to proactively add new customers to its long list of satisfied clients. “After years of organic growth, our board decided to take a more proactive position on growth. Understanding who you are, where you’ve been, and where you are headed is crucial to executing a growth strategy."
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
